Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance
Eva Maria Putz(University of Veterinary Medicine Vienna), Andrea Hoelbl‐Kovacic(University of Veterinary Medicine Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Brian Reichholf(Institute of Molecular Biotechnology), Maria A. Hoelzl(Medical University of Vienna), Veronika Sexl(University of Veterinary Medicine Vienna), Daniela Kern(University of Salzburg), Julia Baeck(University of Veterinary Medicine Vienna), Christian Schuster(Medical University of Vienna), Fritz Aberger(University of Salzburg)
Cited by 16
Related Papers
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303